Skip to main content
Clinical Trials/NCT02378896
NCT02378896
Completed
Not Applicable

Personalized Computerized Inhibitory Control Training for OCD

New York State Psychiatric Institute1 site in 1 country11 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obsessive-Compulsive Disorder
Sponsor
New York State Psychiatric Institute
Enrollment
11
Locations
1
Primary Endpoint
Obsessive-compulsive symptoms measured after 3 weeks of treatment
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

Detailed Description

This study will evaluate the effectiveness of a computerized training program (called Personalized Computerized Inhibitory Training, or PCIT) coupled with cognitive behavioral therapies (CBT) consisting of Exposures and Response Prevention in treating obsessive compulsive disorder (OCD) in patients who previously underwent CBT, but still have residual symptoms.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
January 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Principal diagnosis of OCD (assessed by SCID).
  • Clinically significant OCD symptoms (Y-BOCS score of at least 16).
  • Have a history of completing a trial of at least 1 EX/RP sessions.
  • Have access to a computer or laptop.

Exclusion Criteria

  • Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID).
  • Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system.
  • Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry.
  • Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded).
  • Active suicidality warranting immediate clinical care.

Outcomes

Primary Outcomes

Obsessive-compulsive symptoms measured after 3 weeks of treatment

Time Frame: 3 weeks

measured by Yale Brown Obsessive Compulsive Scale (YBOCS)

Study Sites (1)

Loading locations...

Similar Trials